Skip to main content
  • Accessibility
  • Headlines
  • Coronavirus-News
  • Get-Hooked
  • Technology
  • Education
  • Employment
  • Parasports
  • Ask Bhavna
  • NHBrandView
  • Independent Living
  • Lifestyle
  • NH Videos
×
Newz Hook – Changing Attitudes towards Disability Logo
  • Stories
  • Videos
  • Inclusive
  • NH Voice
  • Login
COVID-19 Notification by Government in Accessible Format

Accessibility Tools

Text Size:

Contrast Scheme:

  • C
  • C

Reset

  • Home
  • Headlines
  • First human trial of coronavirus vaccine begins in US

First human trial of coronavirus vaccine begins in US

coronavirus
Headlines March 18, 2020
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

The first human trial to evaluate a possible vaccine against the new coronavirus has begun in Seattle in the United States. This has raised hopes in the global fight against the disease. However, it may take almost two years before it becomes available. It will have to pass through more trial phases to prove that it is effective and safe.

The vaccine is called mRNA-1273 and was developed by scientists at the US National Institutes of Health (NIH) and biotechnology company Moderna. The trial will enrol 45 healthy adult volunteers from 18 to 55 years over a period of six week. “The first participant received the investigational vaccine this week”, said NIH.

There are currently no approved vaccines or treatments against the coronavirus disease, known as COVID-19. It has infected over 175,000 people across the world since it was first identified in central China in late December.
It has claimed 7,000 lives.

Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority. This Phase 1 study, launched in record speed, is an important first step toward achieving that goal. – Anthony Fauci, Head of Infectious Diseases, National Institutes of Health

The trial will study the impact of different doses delivered by intramuscular injection in the upper arm. Participants will be monitored for side-effects like soreness or fever.

Pharmaceuticals and research labs around the world are racing to develop both treatments and vaccines to the new coronavirus. An antiviral treatment called remdesivir, made by US-based Gilead Sciences, is already in the final stages of clinical trials in Asia and doctors in China have reported it has proven effective in fighting the disease.

According to the World Health Organization, 80% of COVID-19 cases are mild, 14% are severe and about 5% are critical, resulting in severe respiratory illness. Patients with mild cases recover in a week or two while severe cases can take six or more weeks.

Support us to make NewzHook Sustainable – Make a Contribution Today

We need your continued support to enable us work towards Changing Attitudes towards Disability. Help us in our attempt to share the voices of people with disabilities that enable them to participate in the society on an equal footing!

Contribute to Newz Hook

NH Videos

Healing pain through art - Dr. Anubha Mahajan, Founder Chronic Pain India

Contribue to Newz Hook |Disability news. Support us to make NewzHook Sustainable – Make a Contribution Today.

Newsletter

 Subscribe to our Newsletter

Want to feature disability stories or share disability news with the disabled community? Write to:

editor@newzhook.com

Newz Hook - Accessible News

Download App Now!

Videos

View More

Get-hooked

Understanding disabled children & family dynamics

Get-hooked

Artists with disabilities unite for live FB event to support LVPEI programme for disabled people

Get-hooked

Seminar on inclusion and accessibility for the deaf community draws participants from many cities

Get-hooked

Micah, boy with autism tells name for first time & Internet cannot stop adoring the cute video!

Newz Hook Logo

About Newz Hook

Newz Hook | Disability News - media site focusing on Disability Stories and Changing Attitudes towards Disability globally. We highlight disability news, offer inclusive solutions and create accessible collaborations. Our focus is to have Inclusion Champions from across the globe who will share disability stories and news.
Lets come together to change attitudes towards disability!

Newz Hook is reader-supported. When you buy through links on our site, we may earn an affiliate commission.

Follow us on:

Related Links

  • About Us
  • Contact Us
  • Privacy Policy
  • Partner with Newz Hook
  • Embed Newz Hook Timeline
  • Affiliate disclosure
  • Accessibility Statement
  • Contribute to Newz Hook

Our Awards

Zero Project Award Winner 2018
Back To Top
© 2019 All Right Reserved. Inclusive News India Private Limited.

Ask Bhavna

All fields are mandatory unless specified as optional.